+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2020

  • ID: 5189462
  • Report
  • October 2020
  • Region: Global
  • 91 Pages
  • GlobalData
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Anchorvalve
  • Colibri Heart Valve LLC
  • Emory University
  • LivaNova PLC
  • MValve Technologies Ltd.
  • Polares Medical SA
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's Medical Devices sector report, “Transcatheter Mitral Valve Implantation (TMVI) - Medical Devices Pipeline Assessment, 2020“. Transcatheter Mitral Valve is an artificial heart valve made up of natural tissue (biological material mainly derived from cow or bovine) surrounded by a flexible mesh frame known as stent (made of steel or cobalt-chromium) is placed in a long narrow tube known as a catheter.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Mitral Valve Implantation (TMVI) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Mitral Valve Implantation (TMVI) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Mitral Valve Implantation (TMVI) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Anchorvalve
  • Colibri Heart Valve LLC
  • Emory University
  • LivaNova PLC
  • MValve Technologies Ltd.
  • Polares Medical SA

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Transcatheter Mitral Valve Implantation (TMVI) Overview
3 Products under Development
3.1 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
3.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
3.3 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
3.4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
3.5 Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
4 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products under Development by Companies
4.1 Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
4.2 Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
5 Transcatheter Mitral Valve Implantation (TMVI) Companies and Product Overview
5.1 4C Medical Technologies Inc Company Overview
5.1.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Anchorvalve Company Overview
5.2.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
5.3 Annulon Company Overview
5.3.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardiovalve Ltd Company Overview
5.4.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cephea Valve Technologies, Inc. Company Overview
5.5.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.6 Colibri Heart Valve LLC Company Overview
5.6.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 Direct Flow Medical Inc (Inactive) Company Overview
5.7.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.8 Dura LLC Company Overview
5.8.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
5.9 Edwards Lifesciences Corp Company Overview
5.9.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
5.10 Emory University Company Overview
5.10.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Foldax Inc Company Overview
5.11.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 HighLife SAS Company Overview
5.12.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview
5.13 LivaNova PLC Company Overview
5.13.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview
5.14 Medtronic Plc Company Overview
5.14.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Micro Interventional Devices, Inc. Company Overview
5.15.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.16 MitrAssist Ltd. Company Overview
5.16.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.17 MValve Technologies Ltd. Company Overview
5.17.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.18 NaviGate Cardiac Structures, Inc. Company Overview
5.18.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.19 Neovasc Inc Company Overview
5.19.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 NewMed Medical Co Ltd Company Overview
5.20.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.21 P+F Products + Features GmbH Company Overview
5.21.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.22 Polares Medical SA Company Overview
5.22.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview
5.23 Sino Medical Sciences Technology Inc Company Overview
5.23.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview
5.24 Trinity College Dublin Company Overview
5.24.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.25 University College London Company Overview
5.25.1 University College London Pipeline Products & Ongoing Clinical Trials Overview
5.26 Venus MedTech Company Overview
5.26.1 Venus MedTech Pipeline Products & Ongoing Clinical Trials Overview
6 Transcatheter Mitral Valve Implantation (TMVI)- Recent Developments
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer
List of Tables
Table 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Table 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Table 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Table 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
Table 6: Transcatheter Mitral Valve Implantation (TMVI) Companies - Pipeline Products by Stage of Development
Table 7: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Table 8: 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: AltaValve - Product Status
Table 10: AltaValve - Product Description
Table 11: 4C Medical Technologies Inc - Ongoing Clinical Trials Overview
Table 12: AltaValve - AltaValve Early Feasibility Study Protocol
Table 13: Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Status
Table 15: Sutureless Trans-Catheter Mitral Valve Replacement (TMVR) - Product Description
Table 16: Annulon Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Mitral Valve Replacement Device - Product Status
Table 18: Mitral Valve Replacement Device - Product Description
Table 19: Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Cardiovalve Transfemoral Mitral Valve System - Product Status
Table 21: Cardiovalve Transfemoral Mitral Valve System - Product Description
Table 22: Cardiovalve Ltd - Ongoing Clinical Trials Overview
Table 23: Cardiovalve Transfemoral Mitral Valve System - Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk with Severe Mitral Regurgitation
Table 24: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve System for Tricuspid Regurgitation
Table 25: Cardiovalve Transfemoral Mitral Valve System - Early Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System
Table 26: Cardiovalve Transfemoral Mitral Valve System - European Feasibility Study of High Surgical Risk Patients with Severe Mitral Regurgitation Treated with the Cardiovalve Transfemoral Mitral Valve System: AHEAD Study
Table 27: Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Mitral Valve Replacement Device - Product Status
Table 29: Mitral Valve Replacement Device - Product Description
Table 30: Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Mitral Valve - Product Status
Table 32: Mitral Valve - Product Description
Table 33: Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Direct Flow Medical Transcatheter Mitral Valve - Product Status
Table 35: Direct Flow Medical Transcatheter Mitral Valve - Product Description
Table 36: Dura LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Sutra TMVR System - Product Status
Table 38: Sutra TMVR System - Product Description
Table 39: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 40: CardiAQ Mitral Valve - Product Status
Table 41: CardiAQ Mitral Valve - Product Description
List of Figures
Figure 1: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Stage of Development
Figure 2: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Territory
Figure 3: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Regulatory Path
Figure 4: Transcatheter Mitral Valve Implantation (TMVI) - Pipeline Products by Estimated Approval Date
Figure 5: Transcatheter Mitral Valve Implantation (TMVI) - Ongoing Clinical Trials
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • 4C Medical Technologies Inc
  • Anchorvalve
  • Annulon
  • Cardiovalve Ltd
  • Cephea Valve Technologies, Inc.
  • Colibri Heart Valve LLC
  • Direct Flow Medical Inc (Inactive)
  • Dura LLC
  • Edwards Lifesciences Corp
  • Emory University
  • Foldax Inc
  • HighLife SAS
  • LivaNova PLC
  • Medtronic Plc
  • Micro Interventional Devices, Inc.
  • MitrAssist Ltd.
  • MValve Technologies Ltd.
  • NaviGate Cardiac Structures, Inc.
  • Neovasc Inc
  • NewMed Medical Co Ltd
  • P+F Products + Features GmbH
  • Polares Medical SA
  • Sino Medical Sciences Technology Inc
  • Trinity College Dublin
  • University College London
  • Venus MedTech
Note: Product cover images may vary from those shown